Astronics Corporation (ATRO)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-3.73	-16.22	-26.42	-35.75	-25.58	-115.78
Depreciation & Amortization	22.9	24.47	26.1	27.78	29.01	31.85
Other Amortization	2.71	3.19	3.02	-	-	-
Loss (Gain) From Sale of Assets	-	-	-3.43	-11.28	-15.76	-
Asset Writedown & Restructuring Costs	-	-	-	-	-	88.19
Loss (Gain) From Sale of Investments	-	-	-	-	-	3.49
Stock-Based Compensation	6.38	12.03	16.55	11.01	10.66	5.18
Other Operating Activities	43.17	39.36	16.02	13.05	19.05	34.17
Change in Accounts Receivable	-0.9	-21.98	-31.87	-41.65	-14.83	53.93
Change in Inventory	-11.65	-21.55	-13.28	-34.06	-5.15	-13.61
Change in Accounts Payable	-10.08	-17.69	-4.5	27.84	8.61	-9.93
Change in Unearned Revenue	9.11	5.69	-4.84	5.26	-0.24	-7.04
Change in Income Taxes	-1.52	4.5	-1.95	16.13	0.16	-10.44
Change in Other Net Operating Assets	-8.62	18.77	0.63	-6.65	-11.46	-22.67
Operating Cash Flow	47.8	30.57	-23.95	-28.31	-5.53	37.34
Operating Cash Flow Growth	-	-	-	-	-	-12.54%
Capital Expenditures	-11.74	-8.43	-7.64	-7.68	-6.03	-7.46
Divestitures	-	-	3.54	22.06	9.21	-
Other Investing Activities	-	-	-	-	-	1.66
Investing Cash Flow	-11.74	-8.43	-4.11	14.39	3.18	-5.8
Long-Term Debt Issued	-	377.39	139.73	125.83	20	155
Long-Term Debt Repaid	-	-374.89	-131.23	-124.83	-30.9	-172.15
Net Debt Issued (Repaid)	-13.39	2.5	8.5	1	-10.9	-17.15
Issuance of Common Stock	-	-	23.75	0.1	3.4	0.67
Repurchase of Common Stock	-	-	-	-	-	-7.73
Other Financing Activities	-14.49	-17.03	-6.81	-2.51	-	-0.36
Financing Cash Flow	-27.88	-14.53	25.44	-1.41	-7.51	-24.58
Foreign Exchange Rate Adjustments	0.9	-0.49	0.16	-0.64	-0.8	1.54
Net Cash Flow	9.07	7.12	-2.47	-15.98	-10.66	8.51
Free Cash Flow	36.05	22.14	-31.59	-35.99	-11.56	29.88
Free Cash Flow Growth	-	-	-	-	-	-2.38%
Free Cash Flow Margin	4.38%	2.78%	-4.58%	-6.73%	-2.60%	5.94%
Free Cash Flow Per Share	1.02	0.63	-0.95	-1.12	-0.37	0.97
Cash Interest Paid	12.3	19.24	17.69	7.61	5.95	5.83
Cash Income Tax Paid	13.86	3.54	1.96	-9.98	-1.25	-1.54
Levered Free Cash Flow	35.67	23.27	-29.35	-8.82	-9.49	24.63
Unlevered Free Cash Flow	43.35	33.82	-17.79	-2.93	-5.23	28.84
Change in Working Capital	-23.65	-32.26	-55.8	-33.12	-22.91	-9.77

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q